ResearcherThe University of TokyoNo recent work listed
Tomoharu Yamada
Matched on ORCID iD 0000-0001-6312-5706; OpenAlex author ID A5027123819. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 2
- Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors. Co-author DOI 10.1016/j.omto.2022.12.001↗
- Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invas… Co-author DOI 10.1038/s41389-018-0117-8↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Makoto Sano · 2 shared papers, 2019–2023 · strength 0.28
- Paper Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immu… DOI 10.1016/j.omto.2022.12.001↗
- Paper Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal a… DOI 10.1038/s41389-018-0117-8↗
- Kazuhiko Koike · 2 shared papers, 2019–2023 · strength 0.28
- Paper Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immu… DOI 10.1016/j.omto.2022.12.001↗
- Paper Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal a… DOI 10.1038/s41389-018-0117-8↗
- Hideaki Ijichi · 2 shared papers, 2019–2023 · strength 0.28
- Paper Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immu… DOI 10.1016/j.omto.2022.12.001↗
- Paper Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal a… DOI 10.1038/s41389-018-0117-8↗
- Tomoki Todo · 1 shared paper, 2023 · strength 0.19
- Ryota Takahashi · 1 shared paper, 2019 · strength 0.08
- Hiroyuki Isayama · 1 shared paper, 2019 · strength 0.08
- Koji Miyabayashi · 1 shared paper, 2019 · strength 0.08
- Hiroyuki Kato · 1 shared paper, 2019 · strength 0.08
- Harold L. Moses · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.